XML 28 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Convertible Preferred Stock And Stockholders’ Deficit (Unaudited) - USD ($)
Preferred Stock
Previously Reported
Series A Convertible
Preferred Stock
Previously Reported
Series B Convertible
Preferred Stock
Previously Reported
Series C/C-1 Convertible
Preferred Stock
Series A Convertible
Preferred Stock
Series B Convertible
Preferred Stock
Series C/C-1 Convertible
Common Stock
Previously Reported
Common Stock
NorthView Acquisition Corp
Common Stock
Additional Paid-In Capital
Previously Reported
Additional Paid-In Capital
NorthView Acquisition Corp
Additional Paid-In Capital
Accumulated Deficit
Previously Reported
Accumulated Deficit
NorthView Acquisition Corp
Accumulated Deficit
Previously Reported
NorthView Acquisition Corp
Total
Balance Beginning at Dec. 31, 2022       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   $ 5,676,000   $ (619,995) $ (105,447,000)   $ (619,476) $ (99,771,000)
Balance Beginning (in Shares) at Dec. 31, 2022       4,350,314 5,293,175 8,220,445   5,193,750 5,570,901                  
Issuance of common stock upon exercise of stock options               23,000         23,000
Issuance of common stock upon exercise of stock options (in Shares)           33,750                  
Stock-based compensation expense               33,000         33,000
Accretion of common stock to redemption value                       (2,137,638)     (2,137,638)  
Excise tax payable attributable to redemption of common stock                       (1,864,106)     (1,864,106)  
Net income (loss)             1,161,910 (10,281,000)   1,161,910 (10,281,000)
Balance Ending at Dec. 31, 2023       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,732,000   (3,459,829) (115,728,000)   (3,459,310) (109,996,000)
Balance Ending (in Shares) at Dec. 31, 2023       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Stock-based compensation expense               5,000         5,000
Accretion of common stock to redemption value                       (205,732)     (205,732)  
Excise tax payable attributable to redemption of common stock                       (10,884)     (10,884)  
Net income (loss)             (820,277) (2,071,000)   (820,277) (2,071,000)
Balance Ending at Mar. 31, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000       $ 519   $ 5,737,000   $ (117,799,000) (4,496,722)   $ (112,062,000) (4,496,203)  
Balance Ending (in Shares) at Mar. 31, 2024 4,350,314 5,293,175 8,220,445       5,604,651 5,193,750                    
Balance Beginning at Dec. 31, 2023       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,732,000   (3,459,829) (115,728,000)   (3,459,310) $ (109,996,000)
Balance Beginning (in Shares) at Dec. 31, 2023       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Issuance of common stock upon exercise of stock options (in Shares)                                  
Accretion of common stock to redemption value                                 (387,062)  
Balance Ending at Jun. 30, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000         $ 519   5,743,000   (120,209,000) (5,075,539)   (114,466,000) (5,075,020)  
Balance Ending (in Shares) at Jun. 30, 2024 4,350,314 5,293,175 8,220,445       5,604,651 5,193,750                    
Balance Beginning at Dec. 31, 2023       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,732,000   (3,459,829) (115,728,000)   (3,459,310) $ (109,996,000)
Balance Beginning (in Shares) at Dec. 31, 2023       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Issuance of common stock upon exercise of stock options                      
Issuance of common stock upon exercise of stock options (in Shares)                                  
Stock-based compensation expense               21,000         $ 21,000
Accretion of common stock to redemption value                       (768,980)     (768,980)  
Excise tax payable attributable to redemption of common stock                       (16,838)     (16,838)  
Net income (loss)             (8,711,619) (9,230,000)   (8,711,619) (9,230,000)
Balance Ending at Dec. 31, 2024       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,753,000   (12,957,266) (124,958,000)   (12,956,747) (119,205,000)
Balance Ending (in Shares) at Dec. 31, 2024       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Balance Beginning at Mar. 31, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000       $ 519   5,737,000   (117,799,000) (4,496,722)   (112,062,000) (4,496,203)  
Balance Beginning (in Shares) at Mar. 31, 2024 4,350,314 5,293,175 8,220,445       5,604,651 5,193,750                    
Stock-based compensation expense                   6,000           6,000    
Accretion of common stock to redemption value                       (181,330)     (181,330)  
Net income (loss)                     (2,410,000) (397,487)   (2,410,000) (397,487)  
Balance Ending at Jun. 30, 2024 $ 5,231,000 $ 13,701,000 $ 46,217,000         $ 519   $ 5,743,000   $ (120,209,000) (5,075,539)   $ (114,466,000) (5,075,020)  
Balance Ending (in Shares) at Jun. 30, 2024 4,350,314 5,293,175 8,220,445       5,604,651 5,193,750                    
Balance Beginning at Dec. 31, 2024       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,753,000   (12,957,266) (124,958,000)   (12,956,747) (119,205,000)
Balance Beginning (in Shares) at Dec. 31, 2024       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Stock-based compensation expense               5,000         5,000
Accretion of common stock to redemption value                       (155,999)     (155,999)  
Excise tax payable attributable to redemption of common stock                       (65,108)     (65,108)  
Net income (loss)             (1,119,910) (2,716,000)   (1,119,910) (2,716,000)
Balance Ending at Mar. 31, 2025       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,758,000   (14,298,283) (127,674,000)   (14,297,764) (121,916,000)
Balance Ending (in Shares) at Mar. 31, 2025       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Balance Beginning at Dec. 31, 2024       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,753,000   (12,957,266) (124,958,000)   (12,956,747) $ (119,205,000)
Balance Beginning (in Shares) at Dec. 31, 2024       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Issuance of common stock upon exercise of stock options (in Shares)                                  
Accretion of common stock to redemption value                                 (164,969)  
Balance Ending at Jun. 30, 2025       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,840,000   (22,510,739) (130,022,000)   (22,510,220) $ (124,182,000)
Balance Ending (in Shares) at Jun. 30, 2025       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Balance Beginning at Mar. 31, 2025       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   5,758,000   (14,298,283) (127,674,000)   (14,297,764) (121,916,000)
Balance Beginning (in Shares) at Mar. 31, 2025       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651                  
Stock-based compensation expense               82,000         82,000
Accretion of common stock to redemption value                       (8,970)     (8,970)  
Excise tax payable attributable to redemption of common stock                       (6,610)     (6,610)  
Net income (loss)             (8,196,876) (2,348,000)   (8,196,876) (2,348,000)
Balance Ending at Jun. 30, 2025       $ 5,231,000 $ 13,701,000 $ 46,217,000   $ 519   $ 5,840,000   $ (22,510,739) $ (130,022,000)   $ (22,510,220) $ (124,182,000)
Balance Ending (in Shares) at Jun. 30, 2025       4,350,314 5,293,175 8,220,445   5,193,750 5,604,651